These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2498537

  • 1. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
    Pierce GF, Lusher JM, Brownstein AP, Goldsmith JC, Kessler CM.
    JAMA; 1989 Jun 16; 261(23):3434-8. PubMed ID: 2498537
    [Abstract] [Full Text] [Related]

  • 2. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K.
    Behring Inst Mitt; 1983 Aug 16; (73):111-7. PubMed ID: 6433878
    [Abstract] [Full Text] [Related]

  • 3. Spotlight on children. The anxiety factor.
    Gregory M, Foy F.
    Nurs Times; 1983 Aug 16; 84(16):71-2. PubMed ID: 3130616
    [No Abstract] [Full Text] [Related]

  • 4. [Hemophilia and acquired immunodeficiency].
    Allain JP.
    Rev Prat; 1989 Dec 21; 39(30):2674-7. PubMed ID: 2515581
    [Abstract] [Full Text] [Related]

  • 5. [Current clinical aspects in hemophilia treatment].
    Meili EO.
    Schweiz Med Wochenschr; 1989 Sep 30; 119(39):1332-41. PubMed ID: 2508219
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coagulation factor VIII concentrates and the marketplace.
    Cash JD.
    Lancet; 1988 Jun 04; 1(8597):1270. PubMed ID: 2897528
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
    Mannucci PM.
    Vox Sang; 1993 Jun 04; 64(4):197-203. PubMed ID: 8517048
    [Abstract] [Full Text] [Related]

  • 15. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW.
    Vox Sang; 1994 Jun 04; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [Abstract] [Full Text] [Related]

  • 16. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
    McGrath KM, Thomas KB, Herrington RW, Turner PJ, Taylor L, Ekert H, Schiff P, Gust ID.
    Med J Aust; 1985 Jul 08; 143(1):11-3. PubMed ID: 2989666
    [Abstract] [Full Text] [Related]

  • 17. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D, Sugg U, Brackmann HH, Stephan W, Lissner R.
    Dev Biol Stand; 1987 Jul 08; 67():311-7. PubMed ID: 3649316
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Gene therapy for hemophilia: feasible in principle but not yet clinically applicable].
    van der Eb MM, Schagen FH, van Ormondt H, Hoeben RC.
    Ned Tijdschr Geneeskd; 1998 Apr 11; 142(15):840-4. PubMed ID: 9623157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.